AbbVie (ABBV) Assets Average (2013 - 2026)

AbbVie (ABBV) has 14 years of Assets Average data on file, last reported at $135.2 billion in Q1 2026.

• Assets Average for Q1 2026 came in at $135.2 billion, changed 0.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $135.2 billion (changed 0.33% YoY), and the FY2025 annual result was $134.6 billion, changed 0.28% from the prior year.
• Assets Average grew to $135.2 billion in Q1 2026 per ABBV's latest filing, from $133.9 billion in the prior quarter.
• Over five years, Assets Average peaked at $145.4 billion in Q2 2024 and troughed at $133.9 billion in Q4 2025.
• A 5-year average of $138.8 billion and a median of $136.7 billion in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2024 and 2025: Assets Average gained 7.74% in 2024, then slipped 6.01% in 2025.
• A 5-year view of Assets Average shows it stood at $140.1 billion in 2022, then dropped by 3.28% to $135.5 billion in 2023, then climbed by 2.82% to $139.3 billion in 2024, then declined by 3.85% to $133.9 billion in 2025, then grew by 0.96% to $135.2 billion in 2026.
• Business Quant data shows ABBV's Assets Average at $135.2 billion in Q1 2026, $133.9 billion in Q4 2025, and $135.5 billion in Q3 2025.